Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis

Frontiers in Medicine

Zhenmei An¹  Sheyu Li²  Qingyang Shi³  Shengzhao Zhang⁴  Na Su⁴  Ting Xu⁴  Ling Wang⁵ 

[1] Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China;Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China;Department of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China;Department of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China;Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China;West China School of Pharmacy, Sichuan University, Chengdu, China;West China School of Pharmacy, Sichuan University, Chengdu, China;

关键词: febuxostat;    allopurinol;    hyperuricemia;    network meta-analysis;    cardiovascular safety;    Bayesian framework;   

DOI  :  10.3389/fmed.2021.698437

来源: Frontiers

【 授权许可】

CC BY